DK0476233T3 - Humant MK gen og proteinsekvens - Google Patents

Humant MK gen og proteinsekvens

Info

Publication number
DK0476233T3
DK0476233T3 DK91108943.1T DK91108943T DK0476233T3 DK 0476233 T3 DK0476233 T3 DK 0476233T3 DK 91108943 T DK91108943 T DK 91108943T DK 0476233 T3 DK0476233 T3 DK 0476233T3
Authority
DK
Denmark
Prior art keywords
human
gene
protein sequence
protein
production
Prior art date
Application number
DK91108943.1T
Other languages
English (en)
Inventor
Imre Kovesdi
Peter Bohlen
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0476233T3 publication Critical patent/DK0476233T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91108943.1T 1990-08-20 1991-05-31 Humant MK gen og proteinsekvens DK0476233T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56857390A 1990-08-20 1990-08-20
US07/650,795 US5210026A (en) 1990-08-20 1991-02-05 Human mk gene and method of expression

Publications (1)

Publication Number Publication Date
DK0476233T3 true DK0476233T3 (da) 1996-03-11

Family

ID=27074824

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91108943.1T DK0476233T3 (da) 1990-08-20 1991-05-31 Humant MK gen og proteinsekvens

Country Status (13)

Country Link
US (1) US5210026A (da)
EP (1) EP0476233B1 (da)
JP (1) JPH06217778A (da)
KR (1) KR920004570A (da)
AT (1) ATE134219T1 (da)
AU (1) AU636789B2 (da)
CA (1) CA2049370A1 (da)
DE (1) DE69117123T2 (da)
DK (1) DK0476233T3 (da)
ES (1) ES2085928T3 (da)
GR (1) GR3019059T3 (da)
NZ (1) NZ239357A (da)
PT (1) PT98694A (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
GB9225928D0 (en) * 1992-12-11 1993-02-03 Cancer Res Campaign Tech Growth factor
EP0755446B1 (en) * 1994-04-25 2006-09-13 Genentech, Inc. Cardiotrophin and uses therefor
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US7258983B2 (en) * 1994-04-25 2007-08-21 Genentech, Inc. Cardiotrophin-1 compositions and methods for the treatment of tumor
US6472585B1 (en) 1994-04-25 2002-10-29 Genentech, Inc. Cardiotrophin-1 defective mouse
JPH0995454A (ja) * 1995-10-02 1997-04-08 Meiji Milk Prod Co Ltd 抗潰瘍組成物
US5859311A (en) * 1995-11-27 1999-01-12 University Of Kentucky Research Foundation Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use
EP0937461B1 (en) * 1996-07-10 2005-07-06 Meiji Dairies Corporation Use of proteins from the mk family as hematopoietic factor
CA2283954A1 (en) 1997-03-12 1998-09-17 Meiji Milk Products Co., Ltd. Preventive and therapeutic compositions for drug induced nephropathy and hepatitis
AU756279B2 (en) * 1997-07-14 2003-01-09 Medical Therapies Limited Agents comprising Midkine or its inhibitor as active ingredient
US8106009B2 (en) * 1997-09-26 2012-01-31 Medical Therapies Limited Pharmaceutical composition for preventing or treating ischemic diseases
AU1486801A (en) * 1999-11-15 2001-05-30 Curagen Corporation Novel growth factor polypeptides and nucleic acids encoding same
CA2490409A1 (en) 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
GB0228776D0 (en) * 2002-12-10 2003-01-15 Ares Trading Sa Splice variant
US20060014288A1 (en) * 2004-06-23 2006-01-19 Tissuegene, Inc. Nerve regeneration
KR20180057737A (ko) * 2005-06-23 2018-05-30 코오롱 티슈진 인크. 신경보호 효과 화합물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68909254T2 (de) * 1988-01-25 1994-04-28 American Cyanamid Co Heparinbindende Gehirnmitogene.

Also Published As

Publication number Publication date
GR3019059T3 (en) 1996-05-31
EP0476233A1 (en) 1992-03-25
AU8258591A (en) 1992-02-27
DE69117123D1 (de) 1996-03-28
ES2085928T3 (es) 1996-06-16
EP0476233B1 (en) 1996-02-14
PT98694A (pt) 1992-07-31
US5210026A (en) 1993-05-11
ATE134219T1 (de) 1996-02-15
DE69117123T2 (de) 1996-10-02
NZ239357A (en) 1993-07-27
KR920004570A (ko) 1992-03-27
JPH06217778A (ja) 1994-08-09
CA2049370A1 (en) 1992-02-21
AU636789B2 (en) 1993-05-06

Similar Documents

Publication Publication Date Title
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
NO885659D0 (no) Mycobakterielle rekombinanter og peptider.
EP0325474A3 (en) Receptor protein for human b cell stimulating factor-2
DK0574402T3 (da) Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
ES2009238A6 (es) Metodo para producir proteinas de mycobacterium tuberculosis y peptidos antigenicos de las mismas.
DK0555989T3 (da) TGF-beta induceret gen og protein
MX9203519A (es) Metodo de recombinacion para la produccion de inhibidores de proteasa de serina y secuencias de adn utiles para los mismos.
ZA885764B (en) Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology,process,expression vector and recombinant host therefor and pharmaceutical use thereof
DK0688362T3 (da) Kloning og rekombinant fremstilling af vespidgiftenzymer, såsom phospholipase og hyaluronidase, og immunologiske terapier baseret derpå
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
DK0453969T3 (da)
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
DE3880473D1 (de) Expressionsvektoren zur proteinsynthese sowie plasmidreplikons und sequenzkassetten, die zur herstellung solcher vektoren geeignet sind.
DK595187D0 (da) Minactivin og fremgangsmaade til fremstilling deraf
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi